Holen Sie sich die Stockscreener-App
0.4183
0.88%
-0.0037
Gelteq Ltd Aktie (GELS) Neueste Nachrichten
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Gelteq begins clinical trial for veterinary antiparasitic drug - Investing.com
Gelteq begins clinical trial for veterinary antiparasitic drug By Investing.com - Investing.com Australia
Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway - The Manila Times
Gelteq secures up to $3.5M debt financing to support commercialization - MSN
Sommer Ray’s Imaraïs taps Healthy Extracts to make 4M beauty gummies - Stock Titan
TradingKey - TradingKey
Gelteq announces USD $3.5 million strategic debt financing to accelerate commercialization and support revenue growth - marketscreener.com
Gelteq Secures USD $3.5 Million in Debt Financing on May 12, 2026 - geneonline.com
Gelteq secures up to $3.5M debt financing for trials - Investing.com
Gelteq secures up to $3.5M debt financing for trials By Investing.com - Investing.com India
Gelteq Announces USD $3.5 Million Strategic Debt Financing to Accelerate Commercialization and Support Revenue Growth - marketscreener.com
Gelteq lands $3.5M to speed its pharmaceutical and nutraceutical gels - Stock Titan
What makes Gelteq Limited (GELS) a compelling holding for the long term (Hovering) 2026-05-08Trending Entry Points - Newser
What Gelteq Limited (GELS) is doing that smarter investors notice (Institutional Selling) 2026-05-05Social Buzz - Newser
GELS Price Today: Gelteq Limited Stock Price, Quote & Chart | MEXC - MEXC Exchange
GELS (Gelteq Limited) management prioritizes emerging tech vertical investments to drive future sustainable revenue growth.Expert Momentum Signals - Newser
Simon H Szewach Net Worth (2026) - GuruFocus
Bradley Glenn Karp Net Worth (2026) - GuruFocus
Nathan J Givoni Net Worth (2026) - GuruFocus
Paul Michael Wynne Net Worth (2026) - GuruFocus
ETF Watch: Is Gelteq Limited likely to announce a buyback2026 Earnings Surprises & Low Risk High Reward Ideas - baoquankhu1.vn
Market Review: How liquid is Gelteq Limited stockExit Point & Consistent Income Trade Recommendations - baoquankhu1.vn
What support levels matter for Gelteq Limited (GELS) Stock | Price at $0.75, Up 13.12%Trending Momentum Stocks - Newser
Gelteq Ltd (GELS) Cash Flow - TradingKey
Will Gelteq Limited (GELS) Stock Outperform Peers | Price at $0.70, Up 3.09%Stock Analysis Community - Newser
GELS PE Ratio & Valuation, Is GELS Overvalued - Intellectia AI
Five straight record quarters set up Healthy Extracts for a bigger 2026 - Stock Titan
Short Interest in Gelteq Limited Drops 26.3% in March - National Today
Travel Stocks: How does Gelteq Limited compare to its peers2026 Analyst Calls & Safe Capital Growth Stock Tips - baoquankhu1.vn
Gelteq Announces New Product Development Agreement with Melbourne Health for Novel Bowel Polyp Growth Reduction Compound - MSN
Gelteq receives Nasdaq notice for minimum bid price deficiency By Investing.com - za.investing.com
Gelteq receives Nasdaq notice for minimum bid price deficiency - Investing.com
Nasdaq warns Gelteq (NASDAQ: GELS) after shares stay below $1.00 - Stock Titan
Investor Summit Announces Q1 Presenter Line Up (Presentations 3/25, 1-on-1s 3/26) - ChartMill
[Form 3] Gelteq Ltd Initial Statement of Beneficial Ownership - Stock Titan
Gelteq (NASDAQ: GELS) director reports family trust-held positions - Stock Titan
Gelteq Ltd (GELS) officer discloses 500,000 trust-held shares on Form 3 - Stock Titan
Gelteq Ltd (GELS) CEO details indirect share and note holdings - Stock Titan
GELS Earnings History & Surprises | EPS & Revenue Results | GELTEQ LTD (NASDAQ:GELS) - ChartMill
GELS Should I Buy - Intellectia AI
Retail Trends: Will Gelteq Limited outperform small cap indexesTrade Signal Summary & Comprehensive Market Scan Insights - baoquankhu1.vn
Will Gelteq Limited stock hit new highs in YEAR2025 Key Highlights & Growth Focused Entry Reports - mfd.ru
Gelteq and Healthy Extracts to Expand Gel-Based Nutrition Technologies with New Strategic Manufacturing & Commercial Partnership - The Manila Times
IPO Launch: Can Gelteq Limited outperform in the next rallyQuarterly Risk Review & Safe Investment Capital Preservation Plans - baoquankhu1.vn
HUB Cyber Security Receives Compliance Notice from Nasdaq - Intellectia AI
YYAI Director Hongyu Zhou Acquires 4.215M Shares at $1.37, Totaling $5.77M - Intellectia AI
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Inspire Veterinary Partners Stock Drops Amid Market Weakness - Intellectia AI
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Gelteq (NASDAQ:GELS) Trading Up 6.9% – What’s Next? - Defense World
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Trump: Netflix-Paramount Skydance-Warner Bros. Deal? Watch TOON, SEGG, ASST, GELS Small-Cap Stocks - FinancialContent
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
GELS Stock: Market Movements Reflect Strategic Challenges - StocksToTrade
Gelteq announces preclinical results on medicinal cannabinoid absorption - Yahoo Finance
Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Tumble Ahead Of SC Ruling On Trump's Tariffs— Wells Fargo, BP, WeRide In Focus (UPDATED) - Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Gelteq Ltd Reports 22% Bioavailability Increase in Cannabinoid Oral Gel, Shares Surge 50.1% - Intellectia AI
Why Gelteq Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket - Benzinga
Stock Market Today: Dow Jones, Nasdaq 100 Futures Tumble Ahead Of Supreme Court Ruling On Trump's Tariffs—Wells Fargo, BP, WeRide In Focus - Benzinga
Bank of America, Citigroup And 3 Stocks To Watch Heading Into Wednesday - Benzinga
Gelteq reports improved CBD bioavailability with oral gel platform By Investing.com - Investing.com Nigeria
1.38%
1.89%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):